DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Aakaar Medical Technologies Limited — Analysts/Institutional Investor Meet/Con. Call Updates

NSE 1 hr ago·16 Sept 2026, 7:01 am

Aakaar Medical Techno

Aakaar Medical Technologies Limited has informed exchanges about the outcome of its recent institutional investor meet. The company used this platform to update stakeholders on its current business operations and strategic direction. This disclosure ensures transparency and allows investors to stay informed about the company's progress.

For investors, this update is significant as it provides a direct channel for the company to communicate its vision and address market expectations. It offers a clearer picture of the management's outlook, which can be crucial for making informed investment decisions regarding the stock.

Investors should watch for any specific guidance or updates regarding the company's growth trajectory and future plans shared during the interaction. Keeping an eye on the stock's reaction to these developments will help gauge market sentiment and the company's standing in the sector.